Expertise in
1
conditions

Sebastien A. Anguille

Antwerpen, VLG, BE 
Expertise in
1
conditions
Antwerpen, VLG, BE 

Overview

Sebastien Anguille practices practicing medicine in Antwerpen, Belgium.

Mr. Anguille is highly rated in 1 condition, according to our data. His clinical expertise encompasses Wilms Tumor, Metastatic Pleural Tumor, Acute Myeloid Leukemia (AML), and Neurotoxicity Syndromes.

He is actively involved in clinical research, co-authoring 83 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Antwerpen, VLG, Belgium
Other Locations
Edegem, VLG, Belgium
Wilrijk, VLG 2610, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter Observational Belgian Study Assessing the Impact of Newly Started Treatment on the QOL in Patients Suffering From Myelodysplastic Syndromes.
A Multicenter Observational Belgian Study Assessing the Impact of Newly Started Treatment on the QOL in Patients Suffering From Myelodysplastic Syndromes.
Enrollment Status: Completed
Publish Date: March 30, 2025
Wilms' Tumor (WT1) Antigen-targeted Dendritic Cell Vaccination to Prevent Relapse in Adult Patients With Acute Myeloid Leukemia: a Multicenter Randomized Phase II Trial
Wilms' Tumor (WT1) Antigen-targeted Dendritic Cell Vaccination to Prevent Relapse in Adult Patients With Acute Myeloid Leukemia: a Multicenter Randomized Phase II Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 12, 2024
Intervention Type: Biological
Study Drug: Autologous WT1 mRNA-Electroporated Dendritic Cell Vaccine
Study Phase: Phase 2
View 1 Less Clinical Trial

83 Total Publications

Inflammatory mechanisms in the AML bone marrow niche: From pathogenesis to therapy.
Inflammatory mechanisms in the AML bone marrow niche: From pathogenesis to therapy.
Journal: Cytokine & growth factor reviews
Published: July 09, 2026

Frequently Asked Questions about Sebastien A. Anguille

Is Sebastien A. Anguille a top-rated expert for Wilms Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Sebastien A. Anguille is classified as an Distinguished expert for Wilms Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sebastien A. Anguille participate in research or clinical trials?

Yes. Sebastien A. Anguille has published 83 articles and abstracts on conditions like Wilms Tumor. You can view a list of Sebastien A. Anguille's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Anguille's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile